Overall (N=487) Full Sections (n=147) 0.6 mm cores (n=126) 1 mm cores (n=214) P-value
Age (Mean (SD)) 56.1 (11.8) 55.0 (11.3) 55.7 (13.0) 57.0 (11.5) 0.286
Time to diagnosis in days - Median (range) 153 (0, 1729) 118 (43, 884) 663.5 (0, 1729) 97 (3, 830) <0.001
Histology          
Borderline, n (%) 73 (15.0) 34 (23.1) 18 (14.3) 21 (9.8)  
Invasive, n (%) 414 (85.0) 113 (76.9) 108 (85.7) 193 (90.2)  
Serous, n (%) 256 (61.8) 78 (69) 59 (54.6) 119 (61.7) 0.031
Non-Serous, n (%) 110 (26.6) 23 (20.4) 39 (36.1) 48 (24.9)
Clear cell 23 (5.5) 6 (5.3) 5 (4.6) 12 (6.2) 0.264
Endometriod 61 (14.7) 9 (7.9) 26 (24.1) 26 (13.5)
Mucinous 26 (6.3) 8 (7.1) 8 (7.4) 10 (5.2)
Other* 48 (11.6) 12 (10.6) 10 (9.3) 26 (13.4)  
Family History (based on 1st and 2nd degree relatives)
# (%) of subjects with relatives with CRC 86 (17.6) 22 (15) 25 (19.8) 39 (18.2) 0.565
#  (%) of subjects with relatives with EC 28 (5.7) 9 (6.1) 4 (3.2) 15 (7) 0.335
# (%) of subjects with relatives with any HNPCC cancers** 168 (34.5) 52 (35.4) 39 (31) 77 (36) 0.632
*Other includes the following histologies: Carcinoma, unspecified (26), Mixed cell (13), Peritoneal (3), and Transitional cell carcinoma (6); **HNPCC cancers included: colorectum, endometrium, other gastrointestinal tract, urinary tract, ovary and brain; Abbreviations: CRC: colorectal cancer; EC: endometrial cancer.
Table 1: Demographic and Clinical Variables (IHC testing) of Ovarian Cancer Cases by Tumor Specimen Type.